Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications

Roberto Lúcio Muniz Júnior, Isabella Piassi Godói, Edna Afonso Reis, Marina Morgado Garcia, Augusto Afonso Guerra Júnior, Brian Godman, Cristina Mariano Ruas

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

ABSTRACT : Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers’ willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.

LanguageEnglish
Pages473-482
Number of pages10
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume19
Issue number4
Early online date4 Dec 2018
DOIs
Publication statusPublished - 4 Jul 2019

Fingerprint

Brazil
Vaccines
Health Insurance
Disease Outbreaks
Decision Making
Cross-Sectional Studies
Viruses
Infection

Keywords

  • Zika virus
  • Brazil
  • Zika vaccine
  • private pharmaceutical market

Cite this

Lúcio Muniz Júnior, Roberto ; Godói, Isabella Piassi ; Reis, Edna Afonso ; Garcia, Marina Morgado ; Guerra Júnior, Augusto Afonso ; Godman, Brian ; Ruas, Cristina Mariano. / Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications. In: Expert Review of Pharmacoeconomics and Outcomes Research. 2019 ; Vol. 19, No. 4. pp. 473-482.
@article{556e3e042e764ef4bcd4a4e445807797,
title = "Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications",
abstract = "ABSTRACT : Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers’ willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80{\%}, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2{\%}), had completed high school (49.7{\%}), were employed (71.2{\%}), had private health insurance (52.7{\%}), and did not have Zika (96.9{\%}). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.",
keywords = "Zika virus, Brazil, Zika vaccine, private pharmaceutical market",
author = "{L{\'u}cio Muniz J{\'u}nior}, Roberto and God{\'o}i, {Isabella Piassi} and Reis, {Edna Afonso} and Garcia, {Marina Morgado} and {Guerra J{\'u}nior}, {Augusto Afonso} and Brian Godman and Ruas, {Cristina Mariano}",
year = "2019",
month = "7",
day = "4",
doi = "10.1080/14737167.2019.1552136",
language = "English",
volume = "19",
pages = "473--482",
journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
issn = "1473-7167",
number = "4",

}

Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications. / Lúcio Muniz Júnior, Roberto; Godói, Isabella Piassi; Reis, Edna Afonso; Garcia, Marina Morgado; Guerra Júnior, Augusto Afonso; Godman, Brian; Ruas, Cristina Mariano.

In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 19, No. 4, 04.07.2019, p. 473-482.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications

AU - Lúcio Muniz Júnior, Roberto

AU - Godói, Isabella Piassi

AU - Reis, Edna Afonso

AU - Garcia, Marina Morgado

AU - Guerra Júnior, Augusto Afonso

AU - Godman, Brian

AU - Ruas, Cristina Mariano

PY - 2019/7/4

Y1 - 2019/7/4

N2 - ABSTRACT : Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers’ willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.

AB - ABSTRACT : Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers’ willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. Methods: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. Results: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). Conclusion: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.

KW - Zika virus

KW - Brazil

KW - Zika vaccine

KW - private pharmaceutical market

UR - https://www.tandfonline.com/loi/ierp20

U2 - 10.1080/14737167.2019.1552136

DO - 10.1080/14737167.2019.1552136

M3 - Article

VL - 19

SP - 473

EP - 482

JO - Expert Review of Pharmacoeconomics and Outcomes Research

T2 - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

SN - 1473-7167

IS - 4

ER -